Literature DB >> 16556458

Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: the roles of surgery and chemotherapy.

Vivian E von Gruenigen1, Heidi E Frasure, Eric L Jenison, Michael P Hopkins, Karen M Gil.   

Abstract

OBJECTIVES: To prospectively evaluate quality of life (QoL), use of complementary and alternative medicine (CAM), and diet/exercise changes in ovarian cancer patients during the first 6 months following diagnosis.
METHODS: Patients with newly diagnosed ovarian cancer were enrolled pre- or post-operatively and surveyed at 3 and 6 months. The Functional Assessment of Cancer Therapy (FACT-G), Medical Outcomes Survey (SF-36), and CAM/diet/exercise questionnaires were used. Independent samples t test and repeated measures ANOVA were used.
RESULTS: Forty-two patients underwent surgical debulking and staging prior to chemotherapy. Patients completing the initial surveys post-operatively had significantly lower physical FACT-G and SF-36 physical scores compared to patients completing the surveys pre-operatively. In patients completing the baseline survey pre-operatively, there was a decrease in physical scores at 3 months (after surgery and during chemotherapy). There was no change observed at 3 months relative to baseline when patients completed the baseline survey post-operatively. Increases in physical and functional well-being were seen at 6 months relative to 3 months. There were no changes in emotional or social scores over time. CAM use increased over time; main reasons were to improve QoL and relieve symptoms. Alterations in diet and exercise were not seen.
CONCLUSIONS: These data highlight the need to conduct assessments before and after surgery to identify effects due to surgery and/or chemotherapy. Patients may be using CAM during chemotherapy to deal with symptoms and compensate for decreased QoL. Intervention trials should be implemented to increase QoL following surgery and during adjuvant chemotherapy.

Entities:  

Mesh:

Year:  2006        PMID: 16556458     DOI: 10.1016/j.ygyno.2006.01.059

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  29 in total

1.  Use of complementary therapies for cancer symptom management: results of the 2007 National Health Interview Survey.

Authors:  Joel G Anderson; Ann Gill Taylor
Journal:  J Altern Complement Med       Date:  2012-03       Impact factor: 2.579

2.  Obesity is associated with worse quality of life in women with gynecologic malignancies: an opportunity to improve patient-centered outcomes.

Authors:  Kemi M Doll; Alison K Kalinowski; Anna C Snavely; Debra E Irwin; Jeannette T Bensen; Victoria L Bae-Jump; Kenneth H Kim; Linda Van Le; Daniel L Clarke-Pearson; Paola A Gehrig
Journal:  Cancer       Date:  2014-09-23       Impact factor: 6.860

3.  Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy.

Authors:  Eran Ben-Arye; Noah Samuels; Elad Schiff; Orit Gressel Raz; Ilanit Shalom Sharabi; Ofer Lavie
Journal:  Support Care Cancer       Date:  2015-03-10       Impact factor: 3.603

4.  The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group Study.

Authors:  Vivian E von Gruenigen; Helen Q Huang; Karen M Gil; Heidi E Frasure; Deborah K Armstrong; Lari B Wenzel
Journal:  Gynecol Oncol       Date:  2011-11-23       Impact factor: 5.482

5.  A prospective, randomized trial of integrative medicine for women with ovarian cancer.

Authors:  Patricia L Judson; Elizabeth L Dickson; Peter A Argenta; Yin Xiong; Melissa A Geller; Linda F Carson; Rahel Ghebre; Amy L Jonson; Levi S Downs
Journal:  Gynecol Oncol       Date:  2011-08-23       Impact factor: 5.482

6.  Employment and quality of survivorship among women with cancer: domains not captured by quality of life instruments.

Authors:  Linda M Frazier; Virginia A Miller; Douglas V Horbelt; James E Delmore; Brigitte E Miller; Ellen P Averett
Journal:  Cancer Control       Date:  2009-01       Impact factor: 3.302

7.  The health-related quality of life journey of gynecologic oncology surgical patients: Implications for the incorporation of patient-reported outcomes into surgical quality metrics.

Authors:  Kemi M Doll; Emma L Barber; Jeannette T Bensen; Anna C Snavely; Paola A Gehrig
Journal:  Gynecol Oncol       Date:  2016-03-18       Impact factor: 5.482

8.  Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials.

Authors:  Vivian E von Gruenigen; Helen Q Huang; Karen M Gil; Heidi E Gibbons; Bradley J Monk; Peter G Rose; Deborah K Armstrong; David Cella; Lari Wenzel
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

9.  Hot flashes severity, complementary and alternative medicine use, and self-rated health in women with breast cancer.

Authors:  Kavita D Chandwani; Charles E Heckler; Supriya G Mohile; Karen M Mustian; Michelle Janelsins; Luke J Peppone; Peter Bushunow; Patrick J Flynn; Gary R Morrow
Journal:  Explore (NY)       Date:  2014-04-18       Impact factor: 1.775

10.  Pretreatment malnutrition and quality of life - association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study.

Authors:  Brenda Laky; Monika Janda; Srinivas Kondalsamy-Chennakesavan; Geoffrey Cleghorn; Andreas Obermair
Journal:  BMC Cancer       Date:  2010-05-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.